Invention Application
- Patent Title: IMIDAZO-PYRIDAZINE DERIVATIVES AS CASEIN KINASE 1 DELTA/EPSILON INHIBITORS
-
Application No.: US15319028Application Date: 2015-06-18
-
Publication No.: US20170137427A1Publication Date: 2017-05-18
- Inventor: Upender Velaparthi , Selvakumar Kumaravel , Arul Mozhi Selvan Subbiah Karupplah , Shilpa Holehatti Maheshwarappa , Chandrasekhar Reddy Rachamreddy , Mark D. Wittman
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- International Application: PCT/US2015/036380 WO 20150618
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00
Abstract:
The invention provides compounds of Formula (I) and pharmaceutically-acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.
Public/Granted literature
- US09956220B2 Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors Public/Granted day:2018-05-01
Information query
